Observational Study
Copyright ©The Author(s) 2024.
World J Virol. Sep 25, 2024; 13(3): 96369
Published online Sep 25, 2024. doi: 10.5501/wjv.v13.i3.96369
Table 1 Clinical, laboratory, and histopathological characteristics
Parameter
Value
Hepatomegaly24 (26.9)
Splenomegaly19 (23.5)
Ascites0.0
Aspartate transaminase (U/L)49.72 ± 42.67
Alanine transaminase (U/L)58.36 ± 56.40
Prothrombin time (second)13.01 ± 1.16
Hemoglobin (g/dL) 12.42 ± 1.50
White blood cells (× 103/mm3)7.04 ± 2.46
Platelets (× 103/mm3)267.96 ± 102.50
PCR (U/mL827319.64 ± 2415665.23
Fibrosis stage
    F117 (26.5)
    F236 (56.3)
    F311 (17.2)
Activity grade
    Absent: A01 (16.0)
    Minimal: A1-A314 (21.9)
    Mild: A4-A844 (68.8)
    Moderate: A9-A125 (7.8)
    Severe: A12-A180 (0)
Table 2 Liver stiffness, and liver and spleen apparent diffusion coefficient in different fibrosis stages
Noninvasive parameter
F1, n = 17
F2, n = 36
F3, n = 11
aP value
LSM (kPa)4.04 ± 1.414.98 ± 1.637.20 ± 5.210.034
bP = 0.096cP = 0.035
Liver ADC (mm2/s)1.12 ± 0.241.15 ± 0.230.95 ± 0.220.039
bP = 0.0787cP = 0.017
Spleen ADC (mm2/s)1.12 ± 0.231.01 ± 0.150.99 ± 0.260.271
Normalized liver ADC1.01 ± 0.221.16 ± 0.230.99 ± 0.250.036
bP = 0.033cP = 0.016
APRI score0.44 ± 0.420.48 ± 0.290.38 ± 0.370.332
FIB-4 score0.34 ± 0.300.34 ± 0.150.22 ± 0.160.083
Table 3 Correlation of fibrosis and activity with different studied parameters
ParametersFibrosis
Activity
R value
P value
R value
P value
Age in yr0.0680.5940.1590.208
Aspartate transaminase (U/L)-0.0440.7510.1920.160
Alanine transaminase (U/L)0.0920.5010.2420.073
Prothrombin time (second)-0.0660.637-0.1840.188
Hemoglobin (g/dL)0.0410.764-0.0500.718
White blood cells as × 103/mm30.6800.6200.0150.913
Platelets as × 103/mm30.0470.731-0.0320.815
LSM (kPa)0.3380.0080.3850.002
Liver ADC (mm2/s)-0.2990.086-0.2810.840
Spleen ADC (mm2/s)-0.2120.145-0.0190.897
Normalized liver ADC-0.0640.653-0.1480.300
APRI score-0.0030.984-0.0880.549
FIB-4 score-0.1280.3760.1480.305